Why the study?
Does acebutolol reduce blood pressure in hypertensive patients in general practice?
Does acebutolol reduce blood pressure in hypertensive patients in general practice?
Once-daily acebutolol effectively reduces blood pressure in hypertensive patients in a general practice setting.
May support once-daily acebutolol in general practice hypertension; leaves open confirmation via randomized trials.
A three-month open, multicentre trial was carried out in 2132 hypertensive patients under uncontrolled conditions in general practice, to assess the effectiveness and tolerance of acebutolol when given orally as a single morning dose, in the range of 200 to 1200 mg/day. Concomitant antihypertensive therapy was given to 702 patients. Forty-five patients, out of 1893 who were eligible for analysis, showed inadequate blood pressure control and were withdrawn from the study. There were 602 reports of side-effects of adverse reactions attributed to acebutolol in 584 patients, necessitating 120 withdrawals from the trials. The results showed that acebutolol given once daily produces a substantial and progressive reduction in blood pressure over the three months of the trial. The changes from pre-trial values of all haemodynamic assessments measured were statistically significant (p less than 0.001).
No takes yet. Share an insight, caveat, or question.
Baker et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: